Lasdoce, Jaybe Theo C.
HRN: 24-68-24 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/10/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/10/2024
03/16/2024
IV
120mg
Q24h
PCAP C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes